NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

Boksoon Chang1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University School of Medicine

Myung Jae Park1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University School of Medicine

Sue In Choi2 Division of Respiratory and Critical Care Medicine, Department of Internal Medicine

Kwang Ho In2 Division of Respiratory and Critical Care Medicine, Department of Internal Medicine

Chul Hwan Kim3 Department of Pathology, College of Medicine, Korea University, Seoul, South Korea

Seung Hyeun Lee1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University School of MedicineCorrespondence[email protected]

Pages 4625-4633 | Published online: 19 Sep 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
PubMed Web of Science ®Google Scholar
MillerVARielyGJZakowskiMFMolecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinibJ Clin Oncol20082691472147818349398
PubMed Web of Science ®Google Scholar
RobertsPJStinchcombeTEKRAS mutation: should we test for it, and does it matter?J Clin Oncol20133181112112123401440
PubMed Web of Science ®Google Scholar
CoboMIslaDMassutiBCustomizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancerJ Clin Oncol200725192747275417602080
PubMed Web of Science ®Google Scholar
SodjaERijavecMKorenASadikovAKorošecPCuferTThe prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancerRadiol Oncol201650218819627247551
PubMedGoogle Scholar
SureshRAliSAhmadAPhilipPASarkarFHThe role of cancer stem cells in recurrent and drug-resistant lung cancerAdv Exp Med Biol2016890577426703799
PubMed Web of Science ®Google Scholar
JeterCRYangTWangJChaoHPTangDGConcise review: NANOG in cancer stem cells and tumor development: an update and outstanding questionsStem Cells20153382381239025821200
PubMed Web of Science ®Google Scholar
LiXQYangXLZhangGNuclear beta-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancerJ Transl Med20131111423648139
PubMed Web of Science ®Google Scholar
ParkEParkSYSunPLPrognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinomaOncotarget2016727425024251227285762
PubMedGoogle Scholar
DuYMaCWangZLiuZLiuHWangTNanog, a novel prognostic marker for lung cancerSurg Oncol201322422422924018162
PubMed Web of Science ®Google Scholar
YinXLiYWZhangBHCoexpression of stemness factors Oct4 and Nanog predict liver resectionAnn Surg Oncol20121992877288722461131
PubMed Web of Science ®Google Scholar
MengHMZhengPWangXYOver-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancerCancer Biol Ther20109429530220026903
PubMed Web of Science ®Google Scholar
LuYZhuHShanHKnockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cellsCancer Lett2013340111312323872274
PubMed Web of Science ®Google Scholar
GoldstrawPThe 7th edition of TNM in lung cancer: what now?J Thorac Oncol20094667167319461399
PubMed Web of Science ®Google Scholar
EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
PubMed Web of Science ®Google Scholar
LiuYClemBZuba-SurmaEKMouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotypeCell Stem Cell20094433634719341623
PubMedGoogle Scholar
LinYLHanZBXiongFYMalignant transformation of 293 cells induced by ectopic expression of human NanogMol Cell Biochem20113511–210911621246261
PubMed Web of Science ®Google Scholar
JiWJiangZEffect of shRNA-mediated inhibition of Nanog gene expression on the behavior of human gastric cancer cellsOncol Lett20136236737424137331
PubMed Web of Science ®Google Scholar
ChiouSHWangMLChouYTCoexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiationCancer Res20107024104331044421159654
PubMed Web of Science ®Google Scholar
LiuYPYangCJHuangMSCisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signalingCancer Res201373140641623135908
PubMed Web of Science ®Google Scholar
BarrMPGraySGHoffmannACGeneration and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signaturePLoS One201381e5419323349823
PubMed Web of Science ®Google Scholar
SmythMJDunnGPSchreiberRDCancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicityAdv Immunol20069015016730260
PubMed Web of Science ®Google Scholar
NohKHLeeYHJeonJHCancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotypeCancer Res20127271717172722337995
PubMed Web of Science ®Google Scholar
HasmimMNomanMZMessaiYCutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-beta1J Immunol2013191125802580624227785
PubMedGoogle Scholar
HassanKAChenGKalemkerianGPWichaMSBeerDGAn embryonic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinomaClin Cancer Res200915206386639019808871
PubMedGoogle Scholar
FuTYHsiehICChengJTAssociation of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progressionJ Oral Pathol Med2016452899526211876
PubMedGoogle Scholar
WiechertASayginCThiagarajanPSCisplatin induces stemness in ovarian cancerOncotarget2016721305113052227105520
PubMedGoogle Scholar
BourguignonLYPeyrollierKXiaWGiladEHyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cellsJ Biol Chem200828325176351765118441325
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date